10.21147/j.issn.1000-9604.2019.01.06
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 (English version)
1.Diagnosis and dynamic assessment of persistent/recurrent and metastatic differentiated thyroid cancer (prmDTC) Differentiated thyroid cancer (DTC),including papillary,follicular and Hüirthle cell types,accounts for nearly 95% of all thyroid carcinomas.The concept of DTC recurrence or persistence after surgery is still difficult to define due to its indolent nature.The recurrent or persistent tumors in this guideline refer to new lesions or residual tumors found during the follow-up after initial treatments.
31
2019-04-15(万方平台首次上网日期,不代表论文的发表时间)
共18页
99-116